Ara
Toplam kayıt 5, listelenen: 1-5
Screening for Alzheimer's disease using prefrontal resting-state functional near-infrared spectroscopy
(Frontiers Media S.A., 2022)
IntroductionAlzheimer's disease (AD) is neurodegenerative dementia that causes neurovascular dysfunction and cognitive impairment. Currently, 50 million people live with dementia worldwide, and there are nearly 10 million ...
Predicting the effects of repetitive transcranial magnetic stimulation on cognitive functions in patients with alzheimer's disease by automated EEG analysis
(Frontiers Media SA, 2022)
Alzheimer's disease (AD) is a progressive, neurodegenerative brain disorder that generally affects the elderly. Today, after the limited benefit of the pharmacological treatment strategies, numerous noninvasive brain ...
Stratification of the gut microbiota composition landscape across the alzheimer's disease continuum in a Turkish cohort
(American Society for Microbiology, 2022)
Alzheimer's disease (AD) is a heterogeneous disorder that spans a continuum with multiple phases, including preclinical, mild cognitive impairment, and dementia. Unlike for most other chronic diseases, human studies reporting ...
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: A randomised, double-blinded, placebo-controlled phase-II trial
(BioMed Central Ltd, 2023)
Background: Alzheimer’s disease (AD) is associated with metabolic abnormalities linked to critical elements of neurodegeneration. We recently administered combined metabolic activators (CMA) to the AD rat model and observed ...
Farmakolojik tedaviye ilaveten uygulanan tek seans ve tekrarlanan seanslı rTMS’ in Alzheimer Hastalığı’nda bilişsel fonksiyonlara uzun dönemde etkisi
(AVES, 2021)
Amaç: Alzheimer Hastalığı (AH), bilişsel fonksiyonlarda kademeli bir düşüşle karakterize nörodejeneratif ve ilerleyici bir hastalıktır. Farmakolojik
tedavi ve tekrarlı Transkranial Manyetik Stimülasyon (rTMS) AH’de ...